Type 1 Diabetes Treatment Standards and Guidelines for Nephropathy and Retinopathy Developed at UH Case Medical Center

December 20, 2015

Clinical & Molecular Endocrinology – January 2016 - View Full PDF

Saul Genuth, MD

Clinical and Molecular Endocrinology, UH Case Medical Center; Professor of Medicine, Case Western Reserve University School of Medicine

Saul Genuth, MD is an internationally recognized authority in diabetes research who has led several national studies, including the Diabetes Control and Complication Trial (DCCT)which demonstrated that intensive glycemic control resulted in a decrease in diabetic nephropathy and retinopathy in patients with type-1 diabetes.

This landmark study not only altered the management of diabetes, but it also set the current standards and guidelines in treating patients with the disease. The DCCT was followed by another study led by the Division of Endocrinology at Case Western Reserve University, the Epidemiology of Diabetes Interventions and Complications (EDIC) trial, which began in 1994 and is still ongoing. Dr. Genuth led another national study: Bypass, Angioplasty, Revascularization, Investigation in Type-2 Diabetics (BARI 2D), which was completed recently.

To contact Dr. Genuth, please email at Saul.Genuth@UHhospitals.org


All National Institutes of Health (NIH) funding for basic and clinical research is awarded to the School of Medicine at Case Western Reserve University.

Important Links & Numbers

Refer A Patient

Call Direct 866-UH4-CARE (866-844-2273)
or 800-552-8338

Contact a UH Physician Liaison Team Member Direct

Transfer Referral Line

216-844-1111 or

UH Physician Portal

Request UH Physician Portal Access

Find a UH Facility